GDF2 and Hypertension: Conversely, various studies have associated BMP9 with glucose and lipid metabolism because a decrease in the circulating concentrations of BMP9 have been observed in patients who displayed features of metabolic syndrome such as insulin resistance, T2D or arterial hypertension [29–31].